Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 9210.026 | 1.0106 | 1.0232 | 0.9102 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7429.102 | 1.0214 | 1.0174 | 2.4347 | |
| MDA-MB-453 | TNBC | Luminal | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7903.042 | 1.0325 | 1.0564 | 1.1508 | |
| HCC1806 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 9376.026 | 1.0429 | 1.0505 | 1.6827 | |
| HCC1937 | TNBC | Basal A | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7832.042 | 1.0048 | 1.0075 | 1.2810 | |
| MCF 10A | NM | Basal B | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7868.018 | 1.0334 | 1.0314 | 2.1110 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7807.042 | 1.0293 | 1.0287 | 2.0250 |